![Virginia R. Dean](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Virginia R. Dean
Human Resources Officer bij
Obsidian Therapeutics, Inc.
Profiel
Virginia R.
Dean currently works at Obsidian Therapeutics, Inc., as Senior Vice President-Human Resources.
Ms. Dean also formerly worked at Macromedia, Inc., as Director-Human Resources from 2001 to 2004, FleetBoston Financial Corp., as Director-Compensation & Commercial Banks in 2001, The Bridgespan Group, as Director-Human Resources from 2004 to 2007, ARIAD Pharmaceuticals, Inc., as Vice President-Human Resources, Allaire Corp, as Vice President-Human Resources from 2000 to 2001, Acronis AG, as Global Vice President-Human Resources, Tesaro, Inc., as Vice President-Human Resources, Oculis Holding AG, as Chief Human Resources Officer from 2024 to 2025, and Axcella Health, Inc., as Chief People Officer & Senior Vice President.
Ms. Dean received her Masters Business Admin degree from Simmons University and undergraduate degree from the University of Vermont.
Actieve functies van Virginia R. Dean
| Bedrijven | Functie | Begin |
|---|---|---|
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Human Resources Officer | - |
Eerdere bekende functies van Virginia R. Dean
| Bedrijven | Functie | Einde |
|---|---|---|
| OCULIS HOLDING AG | Human Resources Officer | 01-02-2025 |
| AXCA HEALPAR | Human Resources Officer | 14-12-2022 |
The Bridgespan Group
 The Bridgespan Group Miscellaneous Commercial ServicesCommercial Services Provides management strategies and tools | Human Resources Officer | 01-01-2007 |
Macromedia, Inc.
 Macromedia, Inc. Packaged SoftwareTechnology Services Provides software technologies and internet solutions | Human Resources Officer | 01-01-2004 |
Allaire Corp
 Allaire Corp Packaged SoftwareTechnology Services Develops, markets and supports software for Web development applications | Human Resources Officer | 01-01-2001 |
Opleiding van Virginia R. Dean
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
80
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Macromedia, Inc.
Macromedia, Inc. Packaged SoftwareTechnology Services Provides software technologies and internet solutions | Technology Services |
Allaire Corp
Allaire Corp Packaged SoftwareTechnology Services Develops, markets and supports software for Web development applications | Technology Services |
FleetBoston Financial Corp.
 FleetBoston Financial Corp. Major BanksFinance Individually managed equity portfolios emphasize long-term growth and are constructed from a list of between 30 and 50 stocks carefully selected from a universe of about 300 companies. Typically large capitalization, these stocks are identified through a process that combines bottom-up company-by-company analysis with top-down screening. Approved stocks are combined in a portfolio that is deliberately diversified across economic sectors to manage risk while capitalizing on long-term economic expectations and demographic trends. Equities: The firm methodology for equities investing includes a systematic analysis of macroeconomic conditions. To be included in a portfolio a company must: 1) have historically low relative p/e ratio of stock to industry, stock to market and stock to GNP; 2) be growing at a rate greater than its current p/e multiple; 3) have a strong cash flow; 4) have increasing levels of dividends. Stocks are sold when they reach an extreme in the established price range, the fundamentals deteriorate, or there are more compelling buying opportunities available. Balanced & Fixed: The firm uses a combination of economic, international, and political analysis to begin to determine the proper asset allocation between fixed-income and equity investments. Fixed-income parameters are based upon forecasts of trends in economics and interest rates and other technical considerations. The equity portion of the portfolio is determined by establishing a likely range for the market based upon forecasts of earnings, inflation, and corporate price-earnings. In addition, consideration is given to the clients' investment objectives. | Finance |
Acronis AG
 Acronis AG Packaged SoftwareTechnology Services Provides AI-powered backup and cyber security & data protection software solutions | Technology Services |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Simmons University
 Simmons University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Bridgespan Group
The Bridgespan Group Miscellaneous Commercial ServicesCommercial Services Provides management strategies and tools | Commercial Services |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
Oculis Holding AG
 Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
